Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

University of Alberta

$37,600.00

High-throughput siRNA screens for host factors affecting poxvirus replication

FY 2010-11

Summary
Viruses have been participating in an evolutionary duel with the organisms that they infect over a time span that probably goes back to the origins of life on earth. This has led to the evolution of an extraordinarily complex network of host defenses and virus counter defenses, which collectively determines whether or not a virus can establish an infection. By studying how virus-encoded proteins interact with host proteins, we gain new insights into how these cell systems function and new strategies for preventing or treating virus infections. This research concerns poxviruses. These are large DNA viruses that can cause severe diseases in humans and animals and we use as experimental models vaccinia and myxoma viruses. (Vaccinia was used as a vaccine against smallpox and myxoma causes myxomatosis in rabbits.) Our studies consist of three different aims. First, we have discovered that poxviruses encode proteins that increase the intracellular levels of a highly reactive form of oxygen called superoxide. Superoxide plays a role in regulating cell growth and can inhibit processes that lead to cell death. However, it's not known how this works. We have isolated cell lines in which methods other than virus infection are used to upregulate the concentration of superoxide, and we will study what effect this has on cell growth, intracellular signaling, susceptibility to virus infection, and resistance to cell killing. Second, we strongly suspect that poxviruses are messing around with superoxide levels because this affects the activity of cell growth signaling networks. Curiously, these systems are often also mutated in cancer cells and it may explain why myxoma virus can grow in human tumors but not in normal human cells. We will use a method called RNA interference to separately block the activity of >900 enzymes regulating cell signaling, and see how this affects myxoma growth. Finally, these methods can be extended to explore which of the more that 22,000 human genes play a role in supporting, or thwarting, poxvirus growth. We will use our newly established high-throughput robotic screening facility, and large libraries of small interfering RNAs, to survey the whole human genome for genes that play a role in vaccinia virus replication.
Program
Discovery Grants Program - Individual
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
36487-2009
Name nom
Evans, David
Department département
Medical Microbiology and Immunology
Organization id
9
Institution établissement
University of Alberta
Province en
Alberta
Province fr
Alberta
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2010
Competition year année de concours
2009
Award amount
37600
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
33
Committee name en
Molec. & Develop. Genetics
Committee name fr
Gén. moléculaire et dévelop.
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
5202
Research subject group en
Microbiology
Research subject group fr
Microbiologie
Research subject en
Virology
Research subject fr
Virologie
Partie
2
Nb partie
5
Application title
High-throughput siRNA screens for host factors affecting poxvirus replication
Keyword
NSERC
Application summary
Viruses have been participating in an evolutionary duel with the organisms that they infect over a time span that probably goes back to the origins of life on earth. This has led to the evolution of an extraordinarily complex network of host defenses and virus counter defenses, which collectively determines whether or not a virus can establish an infection. By studying how virus-encoded proteins interact with host proteins, we gain new insights into how these cell systems function and new strategies for preventing or treating virus infections. This research concerns poxviruses. These are large DNA viruses that can cause severe diseases in humans and animals and we use as experimental models vaccinia and myxoma viruses. (Vaccinia was used as a vaccine against smallpox and myxoma causes myxomatosis in rabbits.) Our studies consist of three different aims. First, we have discovered that poxviruses encode proteins that increase the intracellular levels of a highly reactive form of oxygen called superoxide. Superoxide plays a role in regulating cell growth and can inhibit processes that lead to cell death. However, it's not known how this works. We have isolated cell lines in which methods other than virus infection are used to upregulate the concentration of superoxide, and we will study what effect this has on cell growth, intracellular signaling, susceptibility to virus infection, and resistance to cell killing. Second, we strongly suspect that poxviruses are messing around with superoxide levels because this affects the activity of cell growth signaling networks. Curiously, these systems are often also mutated in cancer cells and it may explain why myxoma virus can grow in human tumors but not in normal human cells. We will use a method called RNA interference to separately block the activity of >900 enzymes regulating cell signaling, and see how this affects myxoma growth. Finally, these methods can be extended to explore which of the more that 22,000 human genes play a role in supporting, or thwarting, poxvirus growth. We will use our newly established high-throughput robotic screening facility, and large libraries of small interfering RNAs, to survey the whole human genome for genes that play a role in vaccinia virus replication.